首页|羟苯磺酸钙联合氨碘肽滴眼液治疗非增殖期糖尿病视网膜病变的效果

羟苯磺酸钙联合氨碘肽滴眼液治疗非增殖期糖尿病视网膜病变的效果

扫码查看
目的:探讨羟苯磺酸钙联合氨碘肽滴眼液治疗非增殖期糖尿病视网膜病变(nonproliferative diabetic retinopathy,NPDR)的效果。方法:选取2022年5月—2023年8月浏阳市集里医院收治的180例NPDR患者。根据随机数表法将其分为基线组和试验组,各90例。基线组给予氨碘肽滴眼液,试验组在基线组基础上给予羟苯磺酸钙胶囊。比较两组治疗后临床疗效,治疗前后视野相关指标、眼动脉血流、血管内皮功能及不良反应。结果:试验组治疗总有效率高于对照组,差异有统计学意义(P<0。05)。治疗后,两组视野灰度值、黄斑厚度、血管瘤体积、出血斑面积均降低,试验组视野灰度值、黄斑厚度、血管瘤体积、出血斑面积均低于基线组,差异有统计学意义(P<0。05)。治疗后,两组收缩期峰值流速(peak systolic velocity,PSV)、舒张末期流速(end-diastolic velocity,EDV)均升高,阻力指数(resistance index,RI)降低,试验组PSV、EDV均高于基线组,RI低于基线组,差异有统计学意义(P<0。05)。治疗后,两组血管内皮生长因子(vascular endothelial growth factor,VEGF)、胰岛素样生长因子1(insulin-like growth factor 1,IGF-1)水平均降低,试验组VEGF、IGF-1水平均低于基线组,差异有统计学意义(P<0。05)。两组不良反应发生率比较,差异无统计学意义(P>0。05)。结论:羟苯磺酸钙和氨碘肽滴眼液共同治疗NPDR效果较好,可改善患者视野问题和眼底病变,改善眼部血流,能调节血管内皮功能,不良反应少。
Effect of Calcium Dobesilate Combined with Amiotide Eye Drops in the Treatment of Nonproliferative Diabetic Retinopathy
Objective:To explore the effect of Calcium Dobesilate combined with Amiotide Eye Drops in the treatment of nonproliferative diabetic retinopathy (NPDR).Method:A total of 180 patients with NPDR admitted to Liuyang Jili Hospital from May 2022 to August 2023 were selected.They were divided into baseline group and experimental group acorrding to the random number table method,90 cases in each group.The baseline group was given Amiotide Eye Drops,and the experimental group was given Calcium Dobesilate Capsules based on the baseline group.The clinical efficacy,visual field related indexes,ocular artery blood flow,vascular endothelial function before and after treatment and adverse reactions were compared between the two groups.Result:The total effective rate of experimental group was higher than that of baseline group,the difference was statistically significant (P<0.05).After treatment,the grayscale value of visual field,macular thickness,hemangioma volume and blood spot area of both groups were decreased,and the grayscale value of visual field,macular thickness,hemangioma volume and blood spot area of experimental group were all lower than those of baseline group,the differences were statistically significant (P<0.05).After treatment,the peak systolic velocity (PSV) and end-diastolic velocity (EDV) increased in both groups,and the resistance index (RI) decreased,PSV and EDV in experimental groups were higher than those in baseline group,and RI was lower than that in baseline group,the difference was statistically significant (P<0.05).After treatment,the levels of vascular endothelial growth factor (VEGF) and insulin-like growth factor 1 (IGF-1) were decreased in both groups,the levels of VEGF and IGF-1 in experimental groups were lower than those in baseline group,the differences were statistically significant (P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion:The combined treatment of Calcium Dobesilate and Amiodarone Eye Drops has good efficacy in the treatment of NPDR,which can improve the visual field problems and fundus lesions of patients,improve ocular blood flow,regulate endothelial function,and have few adverse reactions.

Nonproliferative diabetic retinopathyAmiotide Eye DropsCalcium DobesilateEndothelial function

吴柳青、杨多

展开 >

浏阳市集里医院(浏阳市眼科医院) 湖南 浏阳410300

非增殖期糖尿病视网膜病变 氨碘肽滴眼液 羟苯磺酸钙 内皮功能

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(29)